Literature DB >> 24326070

Remodeling of ion channel expression may contribute to electrophysiological consequences caused by methamphetamine in vitro and in vivo.

Yi-Hong Qu1, Ka-Pui Leung1, Dong-Fang Qiao1, Dong-Ri Li2, Chao Liu3, Xia Yue4, Hui-Jun Wang5.   

Abstract

Methamphetamine (MA) is a psychostimulant. MA may induce numerous cardiotoxic effects, leading to cardiac arrhythmias, heart failure, eventually leading to sudden cardiac death. The deleterious effects of methamphetamine work in tandem to disrupt the coordinated electrical activity of the heart and have been associated with life-threatening cardiac arrhythmias. Remodeling of ion channels is an important mechanism of arrhythmia. Although arrhythmogenic remodeling involves alterations in ion channel expression, it is yet unknown whether MA induced electrical remodeling by affecting gene expression, and whether the changes in protein expression are paralleled by alterations in mRNA expression. Our study focused on the expression of ion channels which were correlated to the electrical remodeling caused by MA. We used RT-PCR and western blot to assess of the transcript and translate levels of ion channel subunits, including Ito: kv1.4, kv1.7, kv3.4, kv4.2; IK1: kir2.1, kir2.2, kir2.3, kir2.4; and ICa-l: Ca(2+)α1, Ca(2+)β, respectively. The reversible effect of these changes after MA withdrawal was also evaluated. MA caused decrease in mRNA and protein levels in all ion channel subunits in vitro and also in vivo, is at this work. The kv3.4 and all 4 subunits of Kir2.0 family showed significant decrease than the other genes. Most of the channel subunit expression started to reverse after MA withdrawal for 4 weeks and significantly reverse in all of the channel subunits after MA withdrawal for 8 weeks. We found that CACNA1C and Kir2.0 family showed lower recoverability than the others after MA withdrawal for 8 weeks. The reduction of the ion channel expression levels may be the molecular mechanism that mediates the electrical remodeling caused by methamphetamine.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arrhythmias; Calcium channel; Cardiotoxicity; I(Ca-)(l); I(K1); I(to); L-type calcium current; MA; Methamphetamine; NRVMs; Potassium channel; QTc; corrected QT interval; inwardly rectifying potassium current; methamphetamine; neonatal rat ventricular myocytes; transient outward potassium current

Mesh:

Substances:

Year:  2013        PMID: 24326070     DOI: 10.1016/j.bbrc.2013.11.114

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 2.  Methamphetamine Use and Cardiovascular Disease.

Authors:  Christopher G Kevil; Nicholas E Goeders; Matthew D Woolard; Md Shenuarin Bhuiyan; Paari Dominic; Gopi K Kolluru; Connie L Arnold; James G Traylor; A Wayne Orr
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-21       Impact factor: 8.311

3.  CT-1-CP-induced ventricular electrical remodeling in mice.

Authors:  Shu-Fen Chen; Tao-Zhi Wei; Li-Ya Rao; Ming-Guang Xu; Zhan-Ling Dong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-02-12

Review 4.  Stimulant Drugs of Abuse and Cardiac Arrhythmias.

Authors:  Paari Dominic; Javaria Ahmad; Hajra Awwab; Md Shenuarin Bhuiyan; Christopher G Kevil; Nicholas E Goeders; Kevin S Murnane; James C Patterson; Kristin E Sandau; Rakesh Gopinathannair; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-28

5.  Methamphetamine decreases K+ channel function in human fetal astrocytes by activating the trace amine-associated receptor type-1.

Authors:  Sonya Dave; Lihua Chen; Chunjiang Yu; Melanie Seaton; Christina E Khodr; Lena Al-Harthi; Xiu-Ti Hu
Journal:  J Neurochem       Date:  2018-11-19       Impact factor: 5.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.